Composition: each Reuterina daily chew tablet contains a minimum of 100 million (1 x 108) live, freeze-dried colony forming units (CFU) Lactobacillus Reuteri Protectis (strain DSM 17938) until expiry. Contains xylitol and isomalt. When ingested on a regular basis, probiotics should improve or normalise the microbial balance in the human intestines and thereby improve the functioning of the gut.
Customer care line: 011 075 8800. Marketed by: Ascendis Pharma. Manufactured by: BioGaia® Probiotics grounded in evolution Driven by science. Excipients: calcium stearate, citric acid, isomalt, lemon-lime flavouring, palm oil, xylitol (sweetener). Pharmacological classification: D.30.4 pre- & probiotics. Pharmacological action: Probiotics inhibit the colonisation of pathogens in the digestive tract to normalise the microflora through the following actions: antibiosis competing for nutrients and binding sites, alteration of microbial metabolism and stimulation of immunity.
Indications: Probiotics are used to assist in the treatment and prevention of conditions linked to an imbalance in the gastrointestinal microflora, such as diarrhoea, constipation, colic, regurgitation, urogenital infections and gum disease. Reuterina daily helps restore and maintain a healthy balance of intestinal flora in adults, thereby improving the function thereof.